跳至主要内容
临床试验/NCT00732446
NCT00732446已完成3 期

An Evaluation of the Safety and Efficacy of the Administration of a Fixed Combination of Moxifloxacin 0.5% and Dexamethasone 0.1% Eye Drops Compared With the Individual Administration of Moxifloxacin 0.5% and Dexamethasone 0.1% in the Treatment of Bacterial Ocular Inflammation and Infection (Blepharitis and/or Keratitis and/or Conjunctivitis)

Federal University of São Paulo1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2008年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
100
试验地点
1
主要终点
Evaluation of ocular sign/symptoms (hyperemia on bulbar conjunctiva, palpebral conjunctiva, conjunctival exsudates, palpebral erythema at final visit (Day 8)

研究概览

简要总结

Safety and efficacy of antibiotic steroid combination compared with individual administration in the treatment of bacterial ocular inflammation and infection (blepharitis and/or keratitis and/or conjunctivitis).

详细描述

Antibiotic/steroid combination compared to individuals components 8 days of treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with diagnosis of blepharitis and/or keratitis and/or bacterial conjunctivitis

排除标准

  • Uncontrolled glaucoma or intraocular hypertension
  • Wear contact lens during the study
  • Patients with sight in a single eye
  • Suspicious of viral, fungic infection
  • Use of any other ophthalmic drugs during the study
  • Use of immunosuppressant therapy
  • Known or suspected allergy or hypersensibility to any component of study medication

研究组 & 干预措施

2

Active Comparator

antibiotic /steroid combination compared with individual administration of steroid and antibiotic

干预措施: Moxifloxacin (Drug)

2

Active Comparator

antibiotic /steroid combination compared with individual administration of steroid and antibiotic

干预措施: Dexamethasone (Drug)

1

Experimental

combination antibiotic steroid compared with individual administration of steroid and antibiotic - new therapeutic indication

干预措施: Moxifloxacin and Dexamethasone combined (Drug)

结局指标

主要结局

Evaluation of ocular sign/symptoms (hyperemia on bulbar conjunctiva, palpebral conjunctiva, conjunctival exsudates, palpebral erythema at final visit (Day 8)

时间窗: Day 8

次要结局

  • Evaluation of sign and symptoms of blepharitis and/or keratitis and/or bacterial conjunctivitis(Day 8)

研究者

发起方
Federal University of São Paulo
申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Safety/Efficacy of Antibiotic Steroid Combination in... | 临床试验